Notice of registration.
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
Start Supplemental Information
The companies listed below applied to be registered as bulk manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.Start Printed Page 22519
|Patheon Pharmaceuticals, Inc||83 FR 5274||February 6, 2018.|
|Chattem Chemicals, Inc||83 FR 5274||February 6, 2018.|
|INSYS Manufacturing LLC||83 FR 5810||February 9, 2018.|
|Siemens Healthcare Diagnostics Inc||83 FR 5812||February 9, 2018.|
|Cerilliant Corporation||83 FR 5809||February 9, 2018.|
|Noramco, Inc||83 FR 5808||February 9, 2018.|
|Johnson Matthey, Inc||83 FR 7221||February 20, 2018.|
The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed companies.
End Supplemental Information
Dated: May 7, 2018.
John J. Martin,
[FR Doc. 2018-10304 Filed 5-14-18; 8:45 am]
BILLING CODE 4410-09-P